Mark Andrews to Animals
This is a "connection" page, showing publications Mark Andrews has written about Animals.
Connection Strength
0.096
-
Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA. Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence. Bioorg Med Chem Lett. 2011 May 01; 21(9):2715-20.
Score: 0.036
-
Andrews MD, Green MP, Allerton CM, Batchelor DV, Blagg J, Brown AD, Gordon DW, McMurray G, Millns DJ, Nichols CL, Watson L. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists. Bioorg Med Chem Lett. 2009 Sep 15; 19(18):5346-50.
Score: 0.033
-
Winchester WJ, Gore K, Glatt S, Petit W, Gardiner JC, Conlon K, Postlethwaite M, Saintot PP, Roberts S, Gosset JR, Matsuura T, Andrews MD, Glossop PA, Palmer MJ, Clear N, Collins S, Beaumont K, Reynolds DS. Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans. J Pharmacol Exp Ther. 2014 11; 351(2):259-69.
Score: 0.012
-
Allerton CM, Andrews MD, Blagg J, Ellis D, Evrard E, Green MP, Liu KK, McMurray G, Ralph M, Sanderson V, Ward R, Watson L. Design and synthesis of pyridazinone-based 5-HT(2C) agonists. Bioorg Med Chem Lett. 2009 Oct 01; 19(19):5791-5.
Score: 0.008
-
Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA. 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships. Bioorg Med Chem Lett. 2009 May 15; 19(10):2829-34.
Score: 0.008